ormed in 1994, GenBio
is an experienced, fully integrated medical diagnostic company focused
on infectious disease and autoimmune disease diagnostics. GenBio
develops, manufactures and markets extensive lines of infectious
disease and autoimmunity serology products under U.S. FDA and ISO
13485 standards. The Company's demonstrable commercialization expertise,
combined with management’s practical health care industry
experience, has resulted in successful families of products under
GenBio labeling and various foreign labels. GenBio offers all of
our customers the quality required to meet any regulatory standard
and the value needed by laboratories in today’s healthcare
environments. The company has developed multiple intellectual property
licenses from governments and academic institutions contributing
to “cutting edge” product performance. We are dedicated
to serving our customers in every corner of the world with impeccable
support through our network of worldwide distributors specialized
in their individual markets and customer needs.
Keys to GenBio's continuing strategy are the strong focus on rapid
commercialization, well-designed market development strategies
with global application, and a management team dedicated to product
and technology delivery at the earliest possible opportunity.
This includes commercialization of “custom” products
developed for specific world market needs.
GenBio also provides reagents for real time PCR development.